# Phase II Trial of Lung Chemoemobolization

> **NCT05672108** · PHASE2 · RECRUITING · sponsor: **City of Hope Medical Center** · enrollment: 30 (estimated)

## Conditions studied

- Lung Non-Small Cell Carcinoma
- Mediastinal Neoplasm
- Pleural Neoplasm
- Lung Metastases From Any Primary
- Endobronchial Metastases
- Colon Cancer
- Sarcoma

## Interventions

- **PROCEDURE:** Computed Tomography
- **DRUG:** Ethiodized Oil
- **DRUG:** Mitomycin
- **PROCEDURE:** Transarterial Chemoembolization
- **DEVICE:** Tris-acryl Gelatin Microspheres

## Key facts

- **NCT ID:** NCT05672108
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-12
- **Primary completion:** 2027-10-28
- **Final completion:** 2027-10-28
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-03-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05672108

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05672108, "Phase II Trial of Lung Chemoemobolization". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05672108. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*